Testosterone, TRAVERSE, And A Label Change 15 Years In The Making

 
• By Bridget Silverman

The Pink Sheet drug review profile investigates the long and rigorous process behind the FDA’s recent relaxation of the cardiovascular safety warning for testosterone products.

The label revisions for testosterone are the visible results of an extensive safety review. (Shutterstock)

More from Drug Review Profiles

More from Drug Safety